Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
37
Frequently Asked Questions
What is Market Cap of Actinium Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Actinium Pharmaceuticals Inc market cap is $52.72M.
What is the 52-week high for Actinium Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Actinium Pharmaceuticals Inc 52 week high is $2.41 as of September 05, 2025.
What is the 52-week low for Actinium Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Actinium Pharmaceuticals Inc 52 week low is $1.03 as of September 05, 2025.
What is Actinium Pharmaceuticals Inc stock price today?
Actinium Pharmaceuticals Inc stock price today is $1.58.
What was Actinium Pharmaceuticals Inc stock price yesterday?
Actinium Pharmaceuticals Inc stock price yesterday was $1.69.
What is the PE ratio of Actinium Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Actinium Pharmaceuticals Inc’s P/E ratio is -1.28.
What is the Price-to-Book ratio of Actinium Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Actinium Pharmaceuticals Inc P/B ratio is 2.7729.
What is the 50-day moving average of Actinium Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Actinium Pharmaceuticals Inc 50-day moving average is $1.63.
How many employess does Actinium Pharmaceuticals Inc has?